"Androstane-3,17-diol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The unspecified form of the steroid, normally a major metabolite of TESTOSTERONE with androgenic activity. It has been implicated as a regulator of gonadotropin secretion.
| Descriptor ID |
D015113
|
| MeSH Number(s) |
D04.210.500.054.040.080 D06.472.334.851.968.500
|
| Concept/Terms |
Androstane-3,17-diol- Androstane-3,17-diol
- Androstane 3,17 diol
- 5-Androstane-3,17-diol
- 5 Androstane 3,17 diol
|
Below are MeSH descriptors whose meaning is more general than "Androstane-3,17-diol".
Below are MeSH descriptors whose meaning is more specific than "Androstane-3,17-diol".
This graph shows the total number of publications written about "Androstane-3,17-diol" by people in this website by year, and whether "Androstane-3,17-diol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Androstane-3,17-diol" by people in Profiles.
-
Transition from androgenic to neurosteroidal action of 5a-androstane-3a, 17ß-diol through the type A ?-aminobutyric acid receptor in prostate cancer progression. J Steroid Biochem Mol Biol. 2018 04; 178:89-98.
-
5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. J Cell Biochem. 2008 Aug 01; 104(5):1612-24.
-
5alpha-Androstane-3alpha,17beta-diol activates pathway that resembles the epidermal growth factor responsive pathways in stimulating human prostate cancer LNCaP cell proliferation. Prostate Cancer Prostatic Dis. 2004; 7(4):364-74.
-
Hirsutism: metabolic effects of two commonly used oral contraceptives and spironolactone. Contraception. 1991 Aug; 44(2):113-24.